Jhyama (Jampa) Lhamo Gurung

Ms. Jhyama (Jampa) Lhamo Gurung

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
MKMurali R Kuracha
Murali R Kuracha
URUppala Radhakrishna
Uppala Radhakrishna
SKSreenaga V. Kuracha
Sreenaga V. Kuracha
NVNavyasri Vegi
Navyasri Vegi
JGJhyama (Jampa) Lhamo Gurung
Jhyama (Jampa) Lhamo Gurung
BMBenita McVicker
Benita McVicker
The Hippo pathway is highly evolved to maintain tissue homeostasis in diverse species by regulating cell proliferation, differentiation, and apoptosis. In tumor biology, the Hippo pathway is a prime example of signaling molecules involved in cancer progression and metastasis. Hippo core elements LATS1, LATS2, MST1, YAP, and TAZ have critical roles in the maintenance of traditional tissue architecture and cell homeostasis. However, in cancer development, dysregulation of Hippo signaling results in tumor progression and the formation secondary cancers. Hippo components not only transmit biochemical signals but also act as mediators of mechanotransduction pathways during malignant neoplasm development and metastatic disease. This review confers knowledge of Hippo pathway core components and their role in cancer progression and metastasis and highlights the clinical role of Hippo pathway in cancer treatment. The Hippo signaling pathway and its unresolved mechanisms hold great promise as potential therapeutic targets in the emerging field of metastatic cancer research.

5 September 2025 in Biology
Verified
Journal Article
Open access
PDF file
JGJhyama (Jampa) Lhamo Gurung
Jhyama (Jampa) Lhamo Gurung
RTRaju Lama Tamang
Raju Lama Tamang
LMLepakshe Madduri
Lepakshe Madduri
RBRobert G. Bennett
Robert G. Bennett
Edward N. HarrisEdward N. Harris
Edward N. Harris
BMBenita McVicker
Benita McVicker
Stabilin-1 (STAB1) is a multifunctional scavenger receptor expressed by endothelial cells of the liver, spleen, lymph nodes, bone marrow and a subset of macrophages. STAB1 interacts with different ligands and modulates a wide range of functions including cell trafficking, endocytosis, homeostasis, angiogenesis, and tumor vascularization. The role of STAB1 in cancer progression and metastasis first became evident in Stab1 knockout (KO) mice, which developed smaller primary tumors and metastatic foci for some cancers. To date, various clinical cohorts and preclinical rodent studies have shown that STAB1 inhibition is associated with elevated anti-tumor T-cell responses. Moreover, human trials using anti-STAB1 antibody treatment indicate a shift towards immune activation and the potential to overcome cancer treatment resistance experienced with other immunotherapies. Although the role of STAB1 in cancer development and metastasis remains to be defined, STAB1 signaling in tumor-associated macrophages and downstream immune modulation are thought to be crucial mechanisms. Herein, we discuss the role of STAB1 in tumor-associated macrophages in relationship to disease progression and patient outcome.